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Abstract. Fast-dissolving delivery systems (FDDS) have received increasing attention in
the last years. Oral drug delivery is still the preferred route for the administration of
pharmaceutical ingredients. Nevertheless, some patients, e.g. children or elderly people, have
difﬁculties in swallowing solid tablets. In this work, gelatin membranes were produced by
electrospinning, containing an encapsulated therapeutic deep-eutectic solvent (THEDES)
composed by choline chloride/mandelic acid, in a 1:2 molar ratio. A gelatin solution (30% w/
v) with 2% (v/v) of THEDES was used to produce electrospun ﬁbers and the experimental
parameters were optimized. Due to the high surface area of polymer ﬁbers, this type of
construct has wide applicability. With no cytotoxicity effect, and showing a fast-dissolving
release proﬁle in PBS, the gelatin ﬁbers with encapsulated THEDES seem to have promising
applications in the development of new drug delivery systems.
KEY WORDS: anti-bacterial studies; fast-dissolving drug delivery systems; gelatin; mandelic acid;
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INTRODUCTION
The development of new drugs is time-consuming and
expensive. Some of the problems associated to the processing,
and administration of conventional drugs, are associated to
the compound concentration needed and the possibility of
developing of toxic metabolites (1).
The common use of oral capsules administered with
water can be impractical for children and elder people due to
their difﬁculties in swallowing. In an attempt to improve drug
safety and efﬁcacy, alternative methods have been imple-
mented. Controlled and slow-release systems, or systems that
target speciﬁc areas, are some of the drug administration
improvements (1,2). Nevertheless, in order to simplify oral
drug administration, fast-dissolving intraoral drugs offer some
advantages (3). The possibility of using fast-dissolving tablets
not only allows for an extremely quick drug administration
but also avoids physical obstruction (3,4). This type of tablets
is also convenient for patients with low access to water,
disabled or bedridden. Fast-dissolving delivery systems
(FDDS) enable a signiﬁcant increase in drug bioavailability
when compared to common oral administration systems and
allow for a more accurate dosage when compared to orally
administered liquids (3). When in contact with the saliva, the
drug in the FDDS can be absorbed in the mouth, or can be
taken down to the pharynx, and esophagus, by saliva that
passes down to the stomach (5). For the application of an
FDDS system, the excipient or the carrier material used must
exhibit certain chemical, physical and biological properties
(1). Furthermore, this system should present a degradation
time adequate to its function, so that it does not induce an
inﬂammatory response (6). Its degradation products cannot
be toxic and should be readily reabsorbed, or excreted, by the
organism (6). On the other hand, the drug used should not
inﬂuence the carrier matrix, by impacting negatively on its
mechanical resistance or by promoting matrix disintegration.
The drugs used for FDDS systems belong, mostly, to the
class II of the biopharmaceutics classiﬁcation system, due to
their poor water solubility and high tissue permeability (5).
A wide range of natural and synthetic biodegradable
polymers have been studied (7) and are reported in literature,
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e.g. chitosan (8), chitin (9), starch (10), poly-ε-caprolactone
(11), among others (8,12). The application of these biomate-
rials are wide and goes from surgical sutures and implants to
tissue engineering and drug delivery (7), making a signiﬁcant
impact on modern biology and medicine.
Ideally, the biomaterials used for FDDS development
should be from natural sources, not cause any damage or
inﬂammatory response in the host, and be metabolized,
excreted, or even reabsorbed by the human body (6,12).
Being obtained by the hydrolysis of collagen, gelatin is widely
used in clinical processes (13,14). It is non-antigenic, with a
favorable absorbability and relative low cost, when compared to
other compounds (15). Furthermore, gelatin presents some
inherent biological features, since it can accelerate wound healing
and tissue regeneration (15). Furthermore, it is also used as an
ingredient in drug formulations (16), sealant in prostheses and in
several biomedical and medical applications (17).
Deep-eutectic solvents (DES) are a new class of solvents,
with straightforward synthesis and useful properties, making
them interesting alternative solvents for green applications.
DES are a combination of two (or more) compounds that, in
certain molar ratio, suffer a high decrease in the melting point
when compared with its pure constituents (18).
The need of increasing drug bioavailability and develop-
ing safer excipients has led the investigation on DES for the
development of eutectic solvents composed by one or more
active pharmaceutical ingredient (API). This class of DES
was named therapeutic deep-eutectic solvents (THEDES)
(19,20). API in the form of THEDES presents higher
permeability and dissolution rate than its pure form (21). In
this work, it was used as gelatin ﬁbers and mandelic acid was
used as API. According to the ATC code, mandelic acid is an
antibacterial compound for systemic use (ATC code
J01XX06) and it also presents high solubility in water.
Electrospinning is a multicomponent technique for the
production of different nanostructures. Besides typical ﬁbers
from what is commonly known, electrospinning also enables
the production of structures such as core-shell by coaxial
electrospinning, Janus ﬁbers through side-by-side
electrospinning and three layers ﬁbers by using a triaxial
electrospinning setup (22–24). Being a versatile and common
technique in the biopolymer manipulation, mainly in the
bioengineering area (7), electrospinning was used in this work
for the production of gelatin ﬁbers. It allows the production of
thin ﬁbers, with smooth surfaces and high superﬁcial area,
and in some cases ﬁbers with high porosity (25,26).
Therefore, the combination of a THEDESwith a biopolymer
ﬁber structure creates a viable alternative for the design of
biocompatible, biodegradable, drug delivery systems.
Herein, it is reported, as proof-of-concept, the possibility
of producing biocompatible ﬁbers with THEDES. The ﬁbers
were morphologically characterized and their biological
properties were also evaluated in terms of cytotoxicity and
antimicrobial assays.
EXPERIMENTAL SECTION
Chemicals
Gelatin was from Panreac (CULTIMED, gelatin for
bacteriological culture, EINECS: 232–554-6). R-(-)-mandelic
acid was from Alfa Aesar (MandAc; 98%) and choline
chloride was from Sigma-Aldrich (ChCl; ≥98%). All reagents
were used without further puriﬁcation.
Sample Preparation
The choline chloride/mandelic acid (ChCl:MandAc)
THEDES was synthesized in a 1:2 molar ratio. Solid mandelic
acid (melting point 130–134°C) and solid choline chloride
(melting point 302–305°C) were weighed and mixed. The
mixture was kept under stirring at 70°C, until a clear solution
was obtained.
The gelatin solution, in a 30% (w/v) concentration, was
prepared by mixing gelatin in preheated water (40°C),
containing 2% (v/v) of ChCl:MandAc. The mixture was
stirred until dissolution was complete, and a clear and
homogenous solution obtained.
Electrospinning Process
For the electrospinning, a 1-mL syringe ﬁtted with a 23-
gauge needle (internal diameter = 0.41 mm) was used. The
syringe was connected to a syringe pump (KDS100) to control
the feed rate. The needle was electrically linked to a
conducting ring, with a diameter of 15 cm, and both were
directly connected to a high voltage supply (Glassman EL
30 kV). Fiber collection was performed on a ﬁxed collector
coated with aluminum foil. All the equipment was placed
inside an acrylic chamber, for a better control of the operating
parameters, namely temperature and humidity. In order to
ensure the liquid state of the gelatin solution, an electric air
heater was used for heating the metallic needle. The heater
was placed close to the needle while also heating and
homogenizing the temperature inside the acrylic box. Be-
cause of the position of the heater, it was possible to control
the temperature inside the box while assuring the needle
temperature was always above 40°C.
The optimization process was made by ﬁxing all the
parameters but one and assessing the inﬂuence of the latter in
ﬁber morphology. The ﬁber morphology was ﬁrst evaluated
using an optical microscope, and the ﬁbers which presented
smooth and uniform shape were further studied by SEM.
Fiber Characterization: Morphology and Internal
Composition
Scanning electron microscopy (SEM) was used to study
ﬁber morphology. The ﬁbers were sputter-coated with Au, for
15 s, with a Polaron SC502 sputter coater. The microscope
used was DSM 962, from Zeiss.
Fourier transform infrared spectroscopy (FTIR) and
transmission electron microscopy (TEM) were used to
evaluate the ﬁbers’ internal composition. TEM results were
obtained at MicroLab (IST/Universidade de Lisboa) using a
Hitachi 8100, with ThermoNoran light elements EDS detec-
tor. For FITR results, a Tensor 27 FTIR Spectrometer, from
Bruker Optic GmbH, with the help of appropriate software
(OPUS 6.0) was used.
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In Vitro Biological Studies
Cytotoxicity
The cytotoxicity of the ﬁber membranes impregnated
with mandelic acid was evaluated through a standard viability
test according to the ISO/EN 10993 norm (MTS assay). An
immortalized mouse lung ﬁbroblasts cell line (L929), from the
European Collection of Cell Cultures, UK, was maintained in
basal culture medium DMEM (Dulbecco’s modiﬁed Eagle’s
medium; Sigma-Aldrich, Germany), plus 10% FBS (heat-
inactivated fetal bovine serum, Biochrom AG, Germany) and
1% A/B (antibiotic–antimycotic solution, Gibco, UK). Cells
were cultured in a humidiﬁed incubator at 37°C in a 5% CO2
atmosphere. Conﬂuent L929 cells were harvested, were
seeded at a concentration of 1.5 × 104 cells/mL in a 96-well
cell culture plate (BD Biosciences, USA) and were cultured
for 24 h, as described before. Extracts of the ﬁbers were
prepared by immersion of 6 cm2 of a ﬁber membrane in 1 mL
of DMEM medium for 24 h at 37°C and 60 rpm. After 24 h,
the culture medium was replaced by the extract prepared,
which was statically cultured under the culture conditions
previously described. Cell metabolic activity after 72 h was
determined using the Cell Titer 96 Aqueous One Solution
Cell Proliferation Assay (Promega, USA), according to the
instructions of the manufacturer. Absorbance was measured
at 490 nm using a microplate reader (Synergie HT, Bio-Tek,
USA). Optical density was determined for sample and
compared to polystyrene tissue culture plate, used as a
positive control. All cytotoxicity screening tests were
performed in triplicate.
Determination of Antimicrobial Activity
The capacity to inhibit microbial growth of the gelatin
ﬁber membranes with encapsulated THEDES was assessed
by determination of the minimum inhibitory concentration
(MIC). MIC is deﬁned as the lowest concentration of the
antimicrobial agent that will inhibit the visible growth of a
microorganism after overnight incubation (27). To deter-
mine the MIC, the broth macrodilution method was used
with the reference strains Escherichia coli K12 DSM498 and
Staphylococcus aureus NCTC8325. A twofold serial dilution
of the API and THEDES was prepared in sterile LB
medium to achieve decreasing concentrations in six sterile
tubes (for each concentration a replica was prepared). The
initial concentration was mandelic acid (20 mg/mL),
ChCl:MandAc (30 mg/mL) and gelatin with THEDES
(75 mg/mL of gelatin and 30 mg/mL of THEDES). In all
cases, irrespective of the form in which mandelic acid was
tested (pure form, as THEDES, as gelatin encapsulated
THEDES), the initial concentration of mandelic acid was
20 mg/mL. The tubes were inoculated and incubated for 24 h
at 37°C, at 120 rpm.
Quantification of Mandelic Acid in Gelatin Membranes
The amount of mandelic acid impregnated in the
ﬁbers was determined by UV spectroscopy, after immer-
sion of 4 cm2 of ﬁber membrane in 10 mL of PBS
solution (pH 7.4, 37°C). The concentration of mandelic
acid was determined against a calibration curve prepared
with standard concentrations of the active principle (R2 =
0.9924), measured at 260 nm (the wavelength of maximum
absorbance of mandelic acid). The results presented are
an average of three measurements.
Table I. Electrospinning Conditions (Environmental and Process Parameters) when Using an Aqueous Solution with 2% (v/v) ChCl:MandAc
and 30% (w/v) Gelatin
Temperature (°C) Humidity (%) Flow rate (mL/h) Distance (cm) Voltage (kV) Electrospinning result
39–40 20 0.1 18 20 Impossible to produce ﬁbers
30–32 35–40 0.2 16 15 Misaligned and very coiled ﬁbers
20 Some coils and some misaligned ﬁbers
15 17.5 Some coils and some misaligned ﬁbers
18 Some coiled ﬁbers
16 20 Some coiled ﬁbers
18 Uniform and smooth ﬁbers
Fig. 1. SEM image of ﬁbers obtained from aqueous solutions with 2% (v/
v) ChCl:MandAc and 30% (w/v) gelatin. Image ampliﬁcation ×300
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RESULTS AND DISCUSSION
Electrospinning Optimization
As expected, the viscosity of the solution increases with
the concentration of gelatin, promoting faster jelliﬁcation
rates. Previous studies on the production of electrospun
gelatin ﬁbers were used as reference. Zhang et al. reported
that gelatin produces good ﬁbers in a concentration between
30 and 50% (w/v) (28), while Santos et al. concluded that a
concentration of 30% (w/v) was adequate for ﬁber formation
(29). In line with these results, in this present study, uniform
and smooth ﬁbers were obtained with both 30 and 35% (w/v)
gelatin. Nevertheless, at 35% (w/v), due to the higher surface
tension of the solution, a more rigorous control of experi-
mental conditions was necessary.
Environmental andprocess parameters in the electrospinning
were adjusted for theDES/gelatin solution, as indicated in Table I.
For humidity values lower than 30%, jelliﬁcation occurred at the
needle tip. On the other hand, above 40%, the solution started to
formdropletsat theendof theneedle,preventing theformationofa
jet stream.
Temperature was also a conditioning factor, since it was
needed to use temperatures above 30°C to ensure that gelatin
did not became solid inside the syringe. However, at
temperatures higher than 35°C, no ﬁbers were obtained.
Distance and voltage are parameters that inﬂuence ﬁber
morphology. For lower distances and voltages, only
misaligned and coiled ﬁbers were obtained. By increasing
simultaneously distance and voltage to 18 cm and 20 kV,
respectively, it was possible to obtain smooth and uniform
ﬁbers. Flow rates in the range 0.1–0.2 mL/h were tested and
found that this parameter does not have a marked inﬂuence
on the ﬁber morphology.
Fiber Characterization
Gelatin ﬁbers when submitted to stress conditions
assumed a straight conﬁguration (29). However, when the
stress is removed, ﬁbers assume a more disorganized conﬁg-
uration (Fig. 1).
Gelatin is an elastomer and produces ﬁbers with different
conformations, being the helix the most typical shape
observed (29–32). However, variations in electrospinning
parameters are responsible for other conformations, e.g.
helical shape, ﬂat ribbon or a ribbon with two tubes (33).
These morphologies were studied through SEM, and the
results can be seen in Fig. 2.
Figure 3 shows a TEM image of the ﬁbers. By the
interaction between the electron beam and the sample, it is
possible to create an image contrast, where a region appears
darker, or lighter, according to its density.
Darker spots can be seen inside the tubes, which are
attributed to solid ChCl:MandAc.
From Fig. 4, it possible to see the FTIR spectra from the
ﬁbers, and its individual components, gelatin and THEDES.
Gelatin shows typical absorption bands associated to C=O
stretching (ν = 1690–1630 cm−1), and N–H stretching (ν =
3325–3330 cm−1) (34).
Fig. 2. SEM images of ﬁbers obtained from aqueous solutions with 2% (v/v) ChCl:MandAc and 30% (w/v)
gelatin showing different conformations, such as ﬂat ribbon (1), ribbon with two tubes (2) and helix (3).
Image ampliﬁcation ×2000 (left) and ×1000 (right)
Fig. 3. TEM image of ﬁbers obtained from aqueous solutions with
2% (v/v) ChCl:MandAc and 30% (w/v) gelatin
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In the ﬁber spectra, it is also possible to see these two
bands. However, both C=O and N–H bands are shifted to
lower frequencies (1650–1515 and 3350–3180 cm−1,
respectively). This could be due to hydrogen bonding
between gelatin and THEDES (35).
The bands near 1500 and 1400 cm−1 can be assigned to
the skeletal vibration of the mandelic acid aromatic ring,
speciﬁcally due to the C=C stretching within the ring (35).
These bands are observed in THEDES and in the ﬁber
spectra.
TEM, along with FTIR information, allows to conclude
encapsulation of the THEDES within the ﬁbers.
Fiber Dissolution and Mandelic Acid Quantification
A membrane of gelatin ﬁbers with encapsulated
THEDES was immersed in PBS solution. The membrane
immediately dissolved in the buffer, conﬁrming the possibility
to use these gelatin membranes as FDDS. The content of
mandelic acid in the gelatin ﬁber membranes was 3.4 ± 0.4%
(w/w).
In Vitro Biological Studies
Cytotoxicity
Cytotoxicity assays are commonly used for testing
compounds that could possibly compromise the integrity of
the cellular membrane. Herein, the MTS assay for measuring
the cytotoxicity of gelatin ﬁber and gelatin ﬁber with
encapsulated THEDES is used (36). The results can be seen
in Fig. 5. By comparing the results from the cells exposed to
gelatin ﬁber membranes (a) and the ones not exposed (b), it
can be concluded that the membranes with THEDES do not
have any negative inﬂuence on the cell proliferation.
Bacteriological Study
To evaluate the anti-bacterial activity of mandelic acid in
pure form, when part of a THEDES, and when part of a
THEDES encapsulated in gelatin ﬁbers, MIC values were
determined for both Gram-positive (S. aureus) and Gram-
negative bacteria (E. coli), as previously described (21).
Fig. 4. FTIR spectra of a ChCl:MAndAc, b electrospun ﬁbers obtained from aqueous
solutions with 2% (v/v) ChCl:MandAc and 30% (w/v) gelatin and c gelatin
Fig. 5. MTS assay for gelatin ﬁbers with THEDES, where a is the cell
viability in gelatin ﬁber membranes with THEDES and b is the cell
viability in the culture medium used as reference
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Mandelic acid displayed a MIC of 2.5 mg/mL, which is in
agreement with that reported for both bacteria (37). The data
shown in Table II indicates that the antibacterial capacity of
mandelic acid decreases slightly when it is part of the
supramolecular THEDES structure with choline chloride.
After the encapsulation of the THEDES in gelatin ﬁbers,
mandelic acid maintained its antibacterial activity.
CONCLUSION
The design of a fast-dissolving delivery system (FDDS)
comprising electrospun gelatin ﬁbers, with an encapsulated
pharmaceutical compound (THEDES), was successfully
achieved. A mixture of choline chloride and mandelic acid
in a 1:2 molar ratio was used as model THEDES. The
electrospinning parameters were optimized and the ﬁbers
characterized. They exhibit a smooth surface and can adopt
various conformations. Among that, it was possible to
determine the presence of mandelic acid inside the ﬁbers.
This was also conﬁrmed by UV/Vis analysis, upon ﬁber
membrane dissolution in PBS solution.
It was observed that gelatin ﬁber with THEDES were
not cytotoxic. The antimicrobial effect against both Gram-
positive and Gram-negative bacteria was also assessed.
Although a slight decrease in antibacterial activity was
observed, when compared with pure mandelic acid, results
showed that the THEDES and the ﬁbers with THEDES
retained the antibacterial activity.
From this work, new opportunities in the pharmaceutical
area can be openned, through the design of cheaper and
biodegradable delivery mechanisms, using simple and com-
mon techniques.
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